The DOI matches its Crossref record; 600 of the 600 references it cites were found in a registry or an index.
Diagnosis and Treatment of Fetal Cardiac Disease: A Scientific Statement From the American Heart Association
Open accessAbstract
Background—: The goal of this statement is to review available literature and to put forth a scientific statement on the current practice of fetal cardiac medicine, including the diagnosis and management of fetal cardiovascular disease. Methods and Results—: A writing group appointed by the American Heart Association reviewed the available literature pertaining to topics relevant to fetal cardiac medicine, including the diagnosis of congenital heart disease and arrhythmias, assessment of cardiac function and the cardiovascular system, and available treatment options. The American College of Cardiology/American Heart Association classification of recommendations and level of evidence for practice guidelines were applied to the current practice of fetal cardiac medicine. Recommendations relating to the specifics of fetal diagnosis, including the timing of referral for study, indications for referral, and experience suggested for performance and interpretation of studies, are presented. The components of a fetal echocardiogram are described in detail, including descriptions of the assessment of cardiac anatomy, cardiac function, and rhythm. Complementary modalities for fetal cardiac assessment are reviewed, including the use of advanced ultrasound techniques, fetal magnetic resonance imaging, and fetal magnetocardiography and electrocardiography for rhythm assessment. Models for parental counseling and a discussion of parental stress and depression assessments are reviewed. Available fetal therapies, including medical management for arrhythmias or heart failure and closed or open intervention for diseases affecting the cardiovascular system such as twin–twin transfusion syndrome, lung masses, and vascular tumors, are highlighted. Catheter-based intervention strategies to prevent the progression of disease in utero are also discussed. Recommendations for delivery planning strategies for fetuses with congenital heart disease including models based on classification of disease severity and delivery room treatment will be highlighted. Outcome assessment is reviewed to show the benefit of prenatal diagnosis and management as they affect outcome for babies with congenital heart disease. Conclusions—: Fetal cardiac medicine has evolved considerably over the past 2 decades, predominantly in response to advances in imaging technology and innovations in therapies. The diagnosis of cardiac disease in the fetus is mostly made with ultrasound; however, new technologies, including 3- and 4-dimensional echocardiography, magnetic resonance imaging, and fetal electrocardiography and magnetocardiography, are available. Medical and interventional treatments for select diseases and strategies for delivery room care enable stabilization of high-risk fetuses and contribute to improved outcomes. This statement highlights what is currently known and recommended on the basis of evidence and experience in the rapidly advancing and highly specialized field of fetal cardiac care.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“CHD screening can be started at 11 weeks of gestation by using a 4-chamber view (4CV), and sensitivity can increase to 92% at 13 weeks of gestation [5,6].”
From Deep Learning for Improving the Effectiveness of Routine Prenatal Screening for Major Congenital Heart Diseases (2022) · cites this paper as [6]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“congenital heart diseases (CHDs), with an incidence of 6–12/1000 livebirths [46]”
The cited source says what the claim attributes to it.
In the citing paper
“Fetal echocardiography is the gold standard for the diagnosis of congenital heart block. 4”
From Anesthetic management of bed-to-bed surgery for epicardial pacemaker implantation in neonates with congenital complete heart block: Case report (2024) · cites this paper as [4]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography
Nagueh, S. F., Appleton, C. P., Gillebert, T. C., Marino, P. N., Oh, J. K., Smiseth, O. A., Waggoner, A. D., Flachskampf, F. A., Pellikka, P. A., & Evangelista, A. (2009) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2008.11.023 · Cited by 4,367
A Randomized Trial of Prenatal versus Postnatal Repair of Myelomeningocele
Adzick, N. S., Thom, E. A., Spong, C. Y., Brock, J. W. I., Burrows, P. K., Johnson, M. P., Howell, L. J., Farrell, J. A., Dabrowiak, M. E., Sutton, L. N., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1014379 · Cited by 2,244
Lammer, E. J., Chen, D. T., Hoar, R. M., Agnish, N. D., Benke, P. J., Braun, J. T., Curry, C. J., Fernhoff, P. M., Grix, A. W., Lott, I. T., et al. (1985) · New England Journal of Medicine · doi:10.1056/nejm198510033131401 · Cited by 1,942
Mellor, D. H. (1981) · Cited by 1,699
Snijders, R., Noble, P., Sebire, N., Souka, A., & Nicolaides, K. (1998) · The Lancet · doi:10.1016/s0140-6736(97)11280-6 · Cited by 1,572
Tei, C., Ling, L. H., Hodge, D. O., Bailey, K. R., Oh, J. K., Rodeheffer, R. J., Tajik, A. J., & Seward, J. B. (1995) · PubMed · Cited by 1,547
Staging of Twin-Twin Transfusion Syndrome
Quintero, R. A., Morales, W. J., Allen, M. H., Bornick, P. W., Johnson, P. K., & Kruger, M. L. (1999) · Journal of Perinatology · doi:10.1038/sj.jp.7200292 · Cited by 1,465
Endoscopic Laser Surgery versus Serial Amnioreduction for Severe Twin-to-Twin Transfusion Syndrome
Sénat, M., Deprest, J. A., Boulvain, M., Paupe, A., Winer, N., & Ville, Y. G. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032597 · Cited by 1,347
Mor‐Avi, V., Lang, R. M., Badano, L. P., Bëlohlávek, M., Cardim, N. M., Dérumeaux, G., Galderisi, M., Marwick, T. H., Nagueh, S. F., Sengupta, P. P., et al. (2011) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2011.01.015 · Cited by 1,258
Major congenital malformations after first-trimester exposure to ACE inhibitors
Cooper, W. O., Hernandez-Diaz, S., Arbogast, P. G., Dudley, J. A., Dyer, S., Gideon, P. S., Hall, K., & Ray, W. A. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055202 · Cited by 1,192
Research works printed but not linked: 11
- Hagay Z, Reece AReece and Hobbins: Medicine of the Fetus and Mother. Philadelphia, PA; JP Lippincott; 1999.
- 10.7863/ultra.32.6.1067 · DOI
- Food and Drug Administration. Revised 510(k) Diagnostic Ultrasound Guidance for 1993. Rockville, MD: Center for Devices and Radiological Health; 1993.
- 10.1016/S0002-9378(13)70275-8 · DOI
- Chaoui R, Korner H, Bommer C, Goldner B, Bierlich A, Bollmann R.Prenatal diagnosis of heart defects and associated chromosomal aberrations [in German]. Ultraschall Med. 1999;20:177–184.
- 10.1016/S0022-3476(89)80605-5 · DOI
- Ferrer PL. Fetal arrhythmias. In: , Deal B, Wolff GS, Gelband H, eds. Current Concepts in Diagnosis and Treatment of Arrhythmias in Infants and Children. Armonk, NY: Futura Publishing Company, Inc; 1998:17–63.
- 10.1016/j.ajog.2004.09.015 · DOI
- 10.1002/uog.7748 · DOI
- 10.1002/uog.10117 · DOI
- 10.1161/circimaging.109.848432 · DOI
Cited by
Sorted by citations
Schwartz, J. E., Padmanabhan, A., Aqui, N. A., Balogun, R. A., Connelly‐Smith, L. S., Delaney, M., Dunbar, N. M., Witt, V., Wu, Y., & Shaz, B. H. (2016) · Journal of Clinical Apheresis · doi:10.1002/jca.21470 · Cited by 799
Connelly‐Smith, L. S., Alquist, C. R., Aqui, N. A., Hofmann, J. C., Klingel, R., Onwuemene, O. A., Patriquin, C. J., Pham, H. P., Sanchez, A. P., Schneiderman, J., et al. (2023) · Journal of Clinical Apheresis · doi:10.1002/jca.22043 · Cited by 751
Pierpont, M. E., Brueckner, M., Chung, W. K., Garg, V., Lacro, R. V., McGuire, A. L., Mital, S., Priest, J. R., Pu, W. T., Roberts, A., et al. (2018) · Circulation · doi:10.1161/cir.0000000000000606 · Cited by 654
Schwartz, J. E., Winters, J. L., Padmanabhan, A., Balogun, R. A., Delaney, M., Linenberger, M. L., Szczepiorkowski, Z. M., Williams, M. E., Wu, Y., & Shaz, B. H. (2013) · Journal of Clinical Apheresis · doi:10.1002/jca.21276 · Cited by 610
2025 ESC Guidelines for the management of cardiovascular disease and pregnancy
Backer, J. F. A. D., Haugaa, K. H., Hasselberg, N. E., de Hosson, M., Brida, M., Castelletti, S., Cauldwell, M., Cerbai, E., Crotti, L., de Groot, N. M. S., et al. (2025) · European Heart Journal · doi:10.1093/eurheartj/ehaf193 · Cited by 380
Metadata
- Authors
- Donofrio, M. T., Moon-Grady, A. J., Hornberger, L. K., Copel, J. A., Sklansky, M. S., Abuhamad, A., Cuneo, B. F., Huhta, J. C., Jonas, R. A., Krishnan, A., Lacey, S., Lee, W., Michelfelder, E. C., Rempel, G. R., Silverman, N. H., Spray, T. L., Strasburger, J. F., Tworetzky, W., & Rychik, J.
- ORCID
- Venue
- Circulation
- Published
- 2014-05-27
- Volume
- 129
- Issue
- 21
- Pages
- 2183-2242
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2007344602
- Cited by
- 1,275
- References
- 599
- Citations by year
- 2026: 117 · 2025: 128 · 2024: 147 · 2023: 151 · 2022: 119 · 2021: 102 · 2020: 124 · 2019: 92 · 2018: 91 · 2017: 75 · 2016: 72 · 2015: 46 · 2014: 8
- FWCI
- 50.76
- Type
- journal article
- Language
- en
- Update notices
- correction (2014-05-27)
- Open access
- bronze
- doi.org
- Locations
- Circulation (publishedVersion)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Congenital Heart Disease Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Congenital heart defects research
- Health Sciences › Medicine › Surgery › Congenital Anomalies and Fetal Surgery
- Keywords
- congenital heart disease, fetal arrhythmia, fetal echocardiography, fetal MRI, fetal magnetocardiography, fetal electrocardiogram, fetal heart failure, twin-twin transfusion syndrome, delivery planning, prenatal diagnosis, parental counseling, parental depression
- MeSH terms
- American Heart Association, Female, Heart Defects, Congenital, Heart Diseases, Humans, Pregnancy, Prenatal Diagnosis, United States, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
